Skip to main content
. 2022 Jun 1;10:875376. doi: 10.3389/fcell.2022.875376

FIGURE 3.

FIGURE 3

Origins and roles of EVs in CVDs. EVs can be released by cardiovascular system-related cells, such as cardiomyocytes, endothelial cells (ECs), fibroblasts, smooth muscle cells (SMCs), leukocytes, monocytes, and macrophages. EVs mimic the cardioprotective properties by stimulating cell proliferation, improving cardiac survival, activating cell autophagy, promoting angiogenesis, enhancing neovascularization, decreasing cell apoptosis, reducing tissue fibrosis, preventing inflammation, inhibiting cardiovascular remodeling, treating myocardial infarction, reducing oxidative stress levels, and affecting immune cell polarization.